Is microalbuminuria, an early marker of clinical nephropathy, also a cardiovascular risk factor?;La micro-albuminurie, marqueur precoce d'atteinte renale, est-elle aussi un facteur de risque cardiovasculaire?

Annales de Biologie Clinique

Volumn 56, Issue 6, 1998, Pages 671-679

  Raynaud, E ^a,b   Brun, J F ^a   Fedou C ^a   Puech Cathala, A M ^a   Perez Martin A ^a   Orsetti, A ^a  

^a LAPEYRONIE HOSPITAL   (France)

^b UNIV MONTPELLIER   (France)

Author keywords

Cardiovascular risk; Hypertension; Microalbuminuria; Type 1 diabetes; Type 2 diabetes

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER;

ANTIHYPERTENSIVE THERAPY; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIABETIC NEPHROPATHY; HUMAN; KIDNEY DISEASE; MICROALBUMINURIA; PATHOGENESIS; PREDICTION; REVIEW; ALBUMINURIA; ANIMAL; CARDIOVASCULAR DISEASE; GENETIC PREDISPOSITION; GENETICS; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR;

ALBUMINURIA; ANIMALS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; RISK FACTORS;

EID: 0031742872     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Viberti GC, Hill RD, Jarret RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982 ; i : 1430-2.
2. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984 ; 310 : 356-60.
3. Keen H, Chlouverakis C. An immunoassay method for urinary albumin at low concentrations. Lancet 1963 ; ii : 913-6.
4. Mogensen CE, Chachati A, Christensen CK, et al. Microalbuminuria : an early marker of renal involvement in diabetes. Uremia Invest 1985-86 ; 9 : 85-95.
5. Mogensen CE, Hansen KW, Sommer S, et al. Micro-albuminurie : étude dans le diabète, l'hypertension artérielle essentielle et les maladies rénales. In : Hôpital-Necker. Actualités néphrologiques Jean Hamburger. Paris, Flammarion Médecine-Sciences, 1990 : 213-47.
6. Bernard DB. Extrarenal complications of the nephrotic syndrome. Kidney Int 1988 ; 33 : 1184-202.
7. Vestbo E, Damsgaard EM, Froland A, Mogensen CE. Urinary albumin excretion in a population based cohort. Diabetic Med 1995 ; 12 : 488-93.
8. Mogensen CE. Micro-albuminurie : risques cardiovasculaire et rénal. Diabétologie et Facteurs de risque 1997 ; 3 : 153-8.
9. Orsetti A, Fédou C, Puech-Cathala AM. La micro-albuminurie étudiée fraction par fraction au cours des 24 heures chez le sujet normal et chez le diabétique. Ann Biol Clin 1985 ; 43 : 669.
10. Mogensen CE. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 1987 ; 31 : 673-89.
11. Mogensen CE, Keane WF, Bennett PH, et al. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 1995 ; 346 : 1080-4.
12. Bouhanick B, Berrut G, Chameau AM, et al. Predictive value of testing random urine sample to detect microalbuminuria in diabetic subjects during outpatient visits. Diabete Metab 1992 ; 18 : 54-8.
13. Poulsen PL, Mogensen CE. Clinical evaluation of a test for immediate and quantitative determination of urinary albumin-to-creatinine ratio. Diabetes Care 1998 ; 21 : 97-8.
14. Hostetter TH, Troy JL, Brenner BM. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 1981 ; 19 : 410-5.
15. Scholey JW, Meyer TW. Control of glomerular hypertension by insulin administration in diabetic rats. J Clin Invest 1989 ; 83 : 1384-9.
16. Zatz R, Meyer TW, Rennke HG, Brenner BM. Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci USA 1985 ; 82 : 5963-7.
17. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986 ; 77 : 1925-30.
18. Orsetti A, Brun JF, Fédou C, Brunel B. Increased albumin excretion rate during a standardized exercise-test in diabetics with lowered blood filterability. J Mal Vasc 1991 ; 16 : 38-42.
19. Brun JF, Criqui C, Cartry E, Fédou C, Orsetti A. Microalbuminuria in diabetics: possible involvement of hemorheologic factors in baseline excretion but not in exercise-induced rise. Clin Hemorheol 1989 ; 9 : 351-9.
20. Brun JF, Fedou C, Orsetti A. A correlation between microalbuminuria and anti-insulin antibodies in type I diabetics. Horm Metab Res 1989 ; 21 : 372-5.
21. Metcalf PA, Baker JR, Scragg RKR, Dryson E, Scottc AJ, Wild CJ. Albuminuria in people at least 40 years old : effect of alcohol consumption, regular exercise and cigarette smoking. Clin Chem 1993 ; 39 : 1793-7.
22. Sawicki PT, Bender R, Didjurgeit U, Heinemann L, Muhlhauser I, Berger M. Smoking is associated with progression of diabetic nephropathy. Diabetes Care 1994 ; 17 : 126-31.
23. Kasiske BL, O'Donnell MP, Cleary MP, Keane WF. Treatment of hyperlipidemia reduces glomerular injury in obese zucker rats. Kidney Int 1988 ; 33: 667-72.
24. Borch-Johnsen K. Epidemiology of microangiopathy in type I diabetes mellitus. A review. Diabete Metab 1993 ; 19 : 133-7.
25. Mangili R, Bending JJ, Scott G, Li LK, Gupta A, Viberti GC. Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy. N Engl J Med 1988 ; 318 : 146-50.
26. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage : the Steno hypothesis. Diabetologia 1989 ; 32 : 219-26.
27. Marre M, Bernardet P, Gallois Y, et al. Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels and diabetic retinal and renal complications. Diabetes 1994 ; 43 : 384-8.
28. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984 ; 310 : 356-60.
29. Metcalf PA, Baker JR, Scott AJ, Wild CJ, Scragg RKR, Dryson E. Albuminuria in people at least 40 years old : effect of obesity, hypertension and hyperlipidemia. Clin Chem 1992 ; 38 : 1802-8.
30. Vasquez B, Flock EV, Savage PJ, Nagulesparan M, Bennion LJ, Bennett PH. Sustained reduction of proteinuria in type 2 (non insulin-dependent) diabetes following diet-induced reduction of hyperglycemia. Diabetologia 1984 ; 26 : 127-33.
31. Metcalf PA, Baker JR, Scragg RKR, Dryson E, Scott AJ, Wild CJ. Dietary nutrient intakes and slight albuminuria in people at least 40 years old. Clin Chem 1993 ; 39 : 2191-8.
32. Reaven GM. Role of insulin resistance in human disease : syndrome X. 4th International Symposium on multiple risk factors in cardiovascular diseases. Washington, 23-25 avril 1997.
33. Brun JF, Fédou C, Monnier JF, Jourdan N, Orsetti A. Relationships between insulin resistance measured with the minimal model and microalbuminuria in type 2 (non-insulin dependent) diabetics. Endocrinol Metab 1995 ; 2 : 203-13.
34. Nosadini R, Solini A, Velussi M, et al. Impaired insulin-induced glucose uptake by extrahepatic tissue is hallmark of NIDDM patients who have or will develop hypertension and microalbuminuria. Diabetes 1994 ; 43 : 491-9.
35. Bruno G, Cavallo-Perin P, Bargero G, Borra M, d'Errico N, Pagano G. Association of fibrinogen with glycemic control and albumin excretion rate in patients with non-insulin-dependent diabetes mellitus. Ann Intern Med 1996 ; 125 : 653-7.
36. Parving HH, Jensen HA, Mogensen CE, Evrin PE. Increased urinary albumin excretion in benign essential hypertension. Lancet 1974 ; i : 1190-2.
37. Vestbo E, Damsgaard EM, Froland A, Mogensen CE. Clinical features in persons with a family history of diabetes compared to controls (The Second Generation Fredericia Study). J Intern Med 1996 ; 240 : 381-7.
38. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993 ; 329 : 977-86.
39. Marre M, Chatellier G, Leblanc H, Guyenne TT, Menard J, Passa P. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. Br Med J 1988 ; 297 : 1092-5.
40. Mogensen CE. How to protect the kidney in diabetic patients with special reference to IDDM. Diabetes 1997 ; 46 (suppl. 2) : S104-11.
41. Agardh CD, Garcia-Puig G, Charbonnel B, Angelkort B, Barnett AH (on behalf of the multicentre group). Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine. J Human Hypertension 1996 ; 10 : 185-92.